Want to see TDOC full AI Analyst Report?
TDOC Stock Chart & Stats
$5.69
-$0.30(-3.00%)
At close: 4:00 PM EST
$5.69
-$0.30(-3.00%)
Day’s Range― - ―
52-Week Range$4.40 - $9.77
Previous CloseN/A
Volume1.13M
Average Volume (3M)4.51M
Market Cap
$1.64B
Enterprise Value$1.66B
Total Cash (Recent Filing)$750.74M
Total Debt (Recent Filing)$1.04B
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Jul 28, 2026EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding180,513,090
10 Day Avg. Volume4,590,767
30 Day Avg. Volume4,514,035
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.89
Price to Sales (P/S)0.49
P/FCF Ratio4.32
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit1.00
Enterprise Value/Ebitda28.92
Forecast
1Y Price Target
$7.25Price Target Upside27.42% Upside
Rating ConsensusHold
Number of Analyst Covering16
EPS Forecast (FY)-0.91
Revenue Forecast (FY)$2.51B
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation (TTM Operating & Free Cash Flow)Consistent positive operating and free cash flow provides durable internal funding to support operations, pay down debt, and invest in product and insurance rollouts. This cash conversion cushions the business through earnings volatility and reduces reliance on external financing over the next 2–6 months.
Large Integrated Care Membership And Chronic Care TractionA ~101M covered-member base and growing chronic-care enrollments create a sticky B2B revenue foundation and cross-sell runway. Scale in integrated care supports recurring subscription/contract revenue, improves negotiating leverage with payers, and underpins medium-term margin expansion.
Operational Efficiency Gains From AI And Platform ToolsMeasurable AI productivity gains lower per-visit clinical costs and raise therapist throughput sustainably. These structural efficiency improvements support margin recovery as BetterHelp scales under insurance, reduce ongoing operating expenses, and improve unit economics over coming quarters.
Bears Say
Ongoing Negative Profitability And ReturnsSustained negative EBIT and returns limit internal reinvestment and shareholder value creation. Even with cash flow, persistent operating losses mean management must balance growth investments and cost cuts, slowing margin recovery and prolonging the path to durable profitability.
BetterHelp Cash-pay Declines And Margin PressureDeclines in cash-pay users and revenue compress BetterHelp margins and reduce overall consolidated growth. The shift to insurance and visit-based models requires time to scale, creating near- to medium-term revenue mix headwinds and continuing pressure on consolidated profitability.
Elevated Gross Debt And Convertible-note UncertaintyHigh gross leverage and near-term convertible maturities constrain strategic flexibility and raise refinancing risk. Even with improving cash flow, debt-reduction plans must execute; failure or delays would increase financing costs and limit investments in growth initiatives over the next several quarters.
Teladoc News
TDOC FAQ
What was Teladoc Inc.’s price range in the past 12 months?
Teladoc Inc. lowest stock price was $4.40 and its highest was $9.77 in the past 12 months.
What is Teladoc Inc.’s market cap?
Teladoc Inc.’s market cap is $1.64B.
When is Teladoc Inc.’s upcoming earnings report date?
Teladoc Inc.’s upcoming earnings report date is Jul 28, 2026 which is in 18 days.
How were Teladoc Inc.’s earnings last quarter?
Teladoc Inc. released its earnings results on Apr 29, 2026. The company reported -$0.36 earnings per share for the quarter, missing the consensus estimate of -$0.341 by -$0.019.
Is Teladoc Inc. overvalued?
According to Wall Street analysts Teladoc Inc.’s price is currently Undervalued.
Does Teladoc Inc. pay dividends?
Teladoc Inc. does not currently pay dividends.
What is Teladoc Inc.’s EPS estimate?
Teladoc Inc.’s EPS estimate is -0.25.
How many shares outstanding does Teladoc Inc. have?
Teladoc Inc. has 180,513,090 shares outstanding.
What happened to Teladoc Inc.’s price movement after its last earnings report?
Teladoc Inc. reported an EPS of -$0.36 in its last earnings report, missing expectations of -$0.341. Following the earnings report the stock price went up 1.849%.
Which hedge fund is a major shareholder of Teladoc Inc.?
Currently, no hedge funds are holding shares in TDOC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Teladoc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$7.25 (27.42% Upside)
$7.25 (27.42% Upside)
Blogger Sentiment
Neutral
TDOC Sentiment 50%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 689.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 3.9%
Last 30 Days ▲ 3.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.58%
12-Months-Change
Fundamentals
Return on Equity
-12.37%
Trailing 12-Months
Asset Growth
-18.50%
Trailing 12-Months
Company Description
Teladoc Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
TDOC Company Deck
TDOC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call balanced clear progress on strategic priorities—Integrated Care growth and margin improvement, meaningful BetterHelp insurance momentum, AI-driven efficiency gains, and affirmed full-year guidance—against notable near-term challenges including a weakening BetterHelp cash-pay business, margin pressure, implementation timing shifts, free cash flow seasonality and lingering gross debt/convertible note risk. Execution on the insurance rollout and the transition from subscription to visit-based models are key catalysts that underpin upside; therapist capacity and near-term mix effects are the main risks to monitor.View all TDOC earnings summariesTDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
TDOC Stock 12 Month Forecast
Average Price Target
$7.25
▲(27.42% Upside)
Technical Analysis
Ownership Overview
0.66% Insiders
21.58% Mutual Funds
<0.01% Other Institutional Investors
56.84% Public Companies and Individual Investors